Is There an Association between the Use of Epidural Analgesia during Labor and the Development of Autism Spectrum Disorder in the Offspring?—A Review of the Literature
Abstract:Autism spectrum disorders (ASDs) are multifactorial and complex neurodevelopmental conditions usually diagnosed in the early childhood. The etiology of ASDs is commonly described as a genetic predisposition combined with an environmental impact. As a result of broadening of the diagnostic criteria the prevalence of ASDs has been increasing worldwide and the search for the modifiable factors is still on-going. Epidural analgesia (ELA) provides effective pain relief during labor and is currently the most preferr… Show more
“…In a retrospective longitudinal study, Qiu et al observed that epidural analgesia in labour (LEA) is associated with a significantly higher rate of ASD risk along with the increase in the duration of exposure to the medication used in LEA, which caused a series of controversies regarding the methodology of the study [80]. Other studies based on robust epidemiological data and sibling matching analysis claim no significant association between LEA and ASD [81][82][83]. However, in a meta-analysis by Wang et al, it has been mentioned that LEA during birth can associate offspring with more chances of developing ASD [84].…”
Section: Epidural Analgesia In Labour and Asdmentioning
The prescription of drugs for the treatment of infertility or during pregnancy has seen a sharp increase in recent years. The study aimed to review the main drugs used to evaluate the balance of benefits/risks of preconception during infertility treatment or during pregnancy. A 10-year PubMed database was searched to assess the association between medication use and offspring health outcomes. Careful analysis of pharmacovigilance reports regarding the potential risk of certain classes of drugs administered during infertility treatments or during pregnancy and ASD is the main strategy regarding the appropriate neurodevelopment of the offspring.
RezumatPrescrierea de medicamente pentru tratamentul infertilității sau în timpul sarcinii a cunoscut o creștere bruscă în ultimii ani. Studiul și-a propus să sumarizeze principalele medicamente utilizate pentru evaluarea echilibrului beneficii/riscuri ale preconcepției în timpul tratamentului pentru infertilitate sau în timpul sarcinii. Baza de date PubMed, pe o perioadă anterioară de 10 ani, a fost investigată pentru a evalua asocierea dintre utilizarea medicamentelor și rezultatele sănătății descendenților. Analiza atentă a rapoartelor de farmacovigilență cu privire la riscul potențial al anumitor clase de medicamente administrate în timpul tratamentelor pentru infertilitate sau în timpul sarcinii și al tulburării din sfera autismului (TSA) este strategia principală în ceea ce privește neurodezvoltarea adecvată a descendenților.
“…In a retrospective longitudinal study, Qiu et al observed that epidural analgesia in labour (LEA) is associated with a significantly higher rate of ASD risk along with the increase in the duration of exposure to the medication used in LEA, which caused a series of controversies regarding the methodology of the study [80]. Other studies based on robust epidemiological data and sibling matching analysis claim no significant association between LEA and ASD [81][82][83]. However, in a meta-analysis by Wang et al, it has been mentioned that LEA during birth can associate offspring with more chances of developing ASD [84].…”
Section: Epidural Analgesia In Labour and Asdmentioning
The prescription of drugs for the treatment of infertility or during pregnancy has seen a sharp increase in recent years. The study aimed to review the main drugs used to evaluate the balance of benefits/risks of preconception during infertility treatment or during pregnancy. A 10-year PubMed database was searched to assess the association between medication use and offspring health outcomes. Careful analysis of pharmacovigilance reports regarding the potential risk of certain classes of drugs administered during infertility treatments or during pregnancy and ASD is the main strategy regarding the appropriate neurodevelopment of the offspring.
RezumatPrescrierea de medicamente pentru tratamentul infertilității sau în timpul sarcinii a cunoscut o creștere bruscă în ultimii ani. Studiul și-a propus să sumarizeze principalele medicamente utilizate pentru evaluarea echilibrului beneficii/riscuri ale preconcepției în timpul tratamentului pentru infertilitate sau în timpul sarcinii. Baza de date PubMed, pe o perioadă anterioară de 10 ani, a fost investigată pentru a evalua asocierea dintre utilizarea medicamentelor și rezultatele sănătății descendenților. Analiza atentă a rapoartelor de farmacovigilență cu privire la riscul potențial al anumitor clase de medicamente administrate în timpul tratamentelor pentru infertilitate sau în timpul sarcinii și al tulburării din sfera autismului (TSA) este strategia principală în ceea ce privește neurodezvoltarea adecvată a descendenților.
“…21 Several publications have recently addressed a potential association between ASD in a child and its mother's use of epidural analgesia during labour, with conflicting results. 22 A large population study by Qiu et al published in 2020, including approximately 148 000 children, found a 37% increased risk for ASD after a child's exposure to maternal labour epidural analgesia, mainly when used for longer times (adjusted hazard ratio 1.37, 95% CI, 1.23 to 1.53). 23 However, this study may not have accounted for several medical risk factors for autism more common among patients who use epidural analgesia, nor does it provided a plausible mechanism to support a link.…”
BACKGROUND
Controversy exists regarding the association between autism spectrum disorder (ASD) in children whose mother had labour epidural analgesia for their birth, as the few existing investigations have reported mixed findings.
OBJECTIVE
This study aims to evaluate the possibility of an association in our heterogeneous population.
DESIGN
A retrospective population-based cohort study.
SETTING
Vaginal deliveries that took place between the years 2005 and 2017 at Soroka University Medical Center, a tertiary referral hospital in Israel, and a follow-up on the incidence of ASD in the children.
PATIENTS
A hundred and thirty-nine thousand, nine hundred and eighty-one labouring patients and their offspring.
MAIN OUTCOME MEASURES
The incidence of children diagnosed with ASD (both hospital and community-based diagnoses) was compared based on whether their mothers had received labour epidural analgesia during their labour. A Kaplan–Meier survival curve compared cumulative incidence of ASD. A Cox proportional hazards model was used to control for relevant confounders.
RESULTS
Labour epidural analgesia was administered to 33 315 women. Epidural analgesia was more common among high-risk pregnancy groups (including pregnancies complicated with diabetes mellitus, hypertensive disorders, intrauterine growth restriction, and oligohydramnios; P < 0.001). In a Cox proportional hazards model, the association between epidural analgesia during labour and ASD in the children lost statistical significance following adjustment for confounders such as maternal age, gestational age, hypertensive disorders, diabetes mellitus, and ethnicity [adjusted hazard ratio = 1.13, 95% confidence interval (CI), 0.96 to 1.34, P = 0.152].
CONCLUSION
In our population, after adjusting for confounders, epidural analgesia is not independently associated with autism spectrum disorder in the children. These findings enhance our knowledge regarding the safety of epidural analgesia and enable patients to make informed decisions about their pain relief techniques during labour.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.